Mortality After Endoscopic Retrograde Cholangiopancreatography
- Conditions
- Cholangiopancreatography, Endoscopic RetrogradeDeep SedationMortality
- Registration Number
- NCT02983331
- Lead Sponsor
- Gulsah Karaoren
- Brief Summary
In this study, the investigators aimed to overview patients with specific and non-specific complications who admitted to intensive care unit following endoscopic retrograde cholangiopancreatography and had fatal course in the facility
- Detailed Description
The investigators retrospectively reviewed patients who underwent elective or emergent endoscopic retrograde cholangiopancreatography at semi-prone position under pharyngeal anesthesia (lidocaine spray) with routine monitoring (including electrocardiography, non-invasive blood pressure, peripheral capillary oxygen saturation) and standard sedation protocol (midazolam 0.02 mgkg-1; fentanyl, 1 mgkg-1; propofol 1 mgkg-1) between 2011 and 2016 after approval of local ethics committee of Umraniye Training Hospital.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1471
- Patients who underwent elective or emergent ERCP at semi-prone position with routine monitoring and standard sedation protocol
- Patients who discharged to ward after treatment and follow-up in ICU
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of anaesthesia related mortality of the endoscopic retrograde cholangiopancreatographyprocedure under sedation 5 years We identified patients who developed complications during procedure and admitted to intensive care unit (ICU).
Number of Participants With endoscopic retrograde cholangiopancreatography Related complications 5 years We retrospectively reviewed patients who underwent elective or emergent endoscopic retrograde cholangiopancreatography at semi-prone position under pharyngeal anesthesia (lidocaine spray) with routine monitoring (including electrocardiography, non-invasive blood pressure, peripheral capillary oxygen saturation) and standard sedation protocol
- Secondary Outcome Measures
Name Time Method Value of Acute Physiology and Chronic Health Evaluation (APACHE II) score for predicting mortality 5 years Value of Charlson comorbidity index (CCI) score for predicting mortality 5 years
Trial Locations
- Locations (1)
Istanbul Umraniye Training Hospital
🇹🇷Istanbul, Turkey